Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
4.780
+0.190 (4.14%)
At close: May 12, 2025, 4:00 PM
4.820
+0.039 (0.83%)
After-hours: May 12, 2025, 7:24 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.26B in the quarter ending March 31, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to $9.73B, up 8.53% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$9.73B
Revenue Growth
+8.53%
P/S Ratio
0.17
Revenue / Employee
$470,097
Employees
20,700
Market Cap
1.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BHC News
- 5 days ago - Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens - Business Wire
- 6 days ago - Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization - Accesswire
- 12 days ago - Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Bausch Health Announces First Quarter 2025 Results - Accesswire
- 13 days ago - Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System - Accesswire
- 20 days ago - Bausch Health Learns Icahn Has 34% Economic Interest in Shares - WSJ
- 20 days ago - Bausch Health says Carl Icahn has exposure to about 34% of company's shares - Reuters
- 20 days ago - Bausch Health Announces Filing of Supplement to Proxy Statement - Accesswire